Lumere, a US-based medical supplies analytics provider backed by healthcare systems Spectrum Health and HCA Healthcare, has been bought by health industry software firm Global Healthcare Exchange (GHX) for an undisclosed sum.
Founded in 2012, Lumere has created a data management and analytics software platform that gives healthcare providers information about price and efficacy when procuring drugs and medical devices.
GHX will incorporate the technology into a health data governance product, and key members of Lumere’s management team will join the company.
Lumere raised an undisclosed amount in a February 2019 round led by growth equity firm Heritage Group that also featured HCA Healthcare and Spectrum Health’s corporate venturing unit, Spectrum Health Ventures.
Heritage Group had also led a $10m round for Lumere – then called Procured Health – in 2016 that included HCA’s Health Insight Capital vehicle, after a $4m series A in 2014 led by FCA Venture Partners, the VC management arm of investment firm Clayton Associates.
Lumere had already secured $1.1m from F-Prime Capital, the VC subsidiary of financial services and investment group Fidelity then known as Fidelity Biosciences, in addition to Silicon Badia, Zimmerman Ventures, Bessemer Venture Partners and assorted angel investors in 2012 .